Taunia MarkvickaAs the chief commercial officer of Symbiomix Therapeutics in Newark, New Jersey, Taunia Markvicka oversees the comprehensive suite of operations involved in bringing the company’s proprietary biopharmaceutical products to market, setting commercial startegy, and positioning the commercialization plan with investors. Her previous industry experience includes tenures as senior vice president and chief commercial officer of Pacira Pharmaceuticals and marketing lead, surgery operations with The Medicines Company. Taunia Markvicka also provided leadership insight for commercial strategy, clinical trial operations, and was chair of the compensation committee as a board member with Cormedix.
Earlier in her career, Taunia Markvicka spent several years with Watson Pharmaceuticals, joining the company as a product manager in 1996, via their acquisition of CoCensys, working her way up to leadership of sales and marketing director of urology and general products. She got her professional start as a pharmacist at Bergan Mercy Medical Center, Omaha, Nebraska, followed by Saint Barnabas Medical Center in Livingston, New Jersey, and a postdoctoral fellow/adjunct faculty member with Novartis Pharmaceuticals/Rutgers University in New Brunswick, New Jersey.
A graduate of Creighton University and The University of Nebraska Medical Center, Dr. Markvicka holds Doctorate of Pharmacy, and an MBA from Saint Joseph’s University.